China Digital Health Report 2021

Available exclusively through SCMP Research

China Digital Health Report 2021

COVID-19 has accelerated the growth of digital health globally, especially in China. But what does this mean for your business and the industry at large?

Make better business decisions with an insider's understanding of the China digital health market landscape, key players, opportunities, and challenges. Get key insights from the most comprehensive English-language resource on China's burgeoning digital health industry.

USD $400

Click here to view the sample pages

120+ page report with data, analyses, and market insights with 200+ companies

5 closed-door webinars led by influential senior executives in digital health

+ live Q&A sessions with executives and SCMP reporters

4 case studies covering vital sectors in digital health

WHAT'S INSIDE

Report Overview

Digital Health at a Glance
Overview of digital health, overview of digital health in China
Sectors of Digital Health
Internet healthcare, AI in healthcare, healthcare IT, big data in healthcare
Head-to-Head on Digital Health
Comparison between China, Australia, Germany, Japan, United Kingdom, and the United States in their respective digital health capabilities — policy support, adoption rate, patent applications, and status of digital health start-ups
Key Questions about Digital Health
Has digital health helped alleviate the imbalance in healthcare resources? Has digital health reduced out-of-pocket health expenditure? Has digital health helped pharma companies reduce drug prices and stay competitive?

4 Deep-dive Sectors

Features data & analyses, market insights, and case studies

Internet Healthcare

Major policies, milestones, market size, opportunities and challenges
Overview and analysis of Internet hospitals
Online pharmacies and online communities
Case study on Ping An Good Doctor - Leveraging network effect to diversify revenue model
Includes a list of ~40 industry leaders in Internet healthcare

AI in Healthcare

Major policies, milestones, market size, funding, opportunities and challenges
Drug development and assisted diagnosis
Medical imaging , medical robotics and health management
Case study on XtalPi - Making a case with crystalized R&D results
Includes a list of ~100 key players in AI in healthcare

Healthcare IT

Major policies, milestones, market size, opportunities and challenges
Evolution and competitive landscape of Hospital Core Management Systems
Case study on Winning Health - Differentiating through innovations
Includes a list of ~40 key players in healthcare IT

Big Data in Healthcare

Major policies, milestones, market size, opportunities and challenges
Overview of government initiatives of big data in healthcare
Generate, collect, integrate, and analyse big data
Case study on Burning Rock - Addressing unmet clinical needs
Includes a list of ~60 key players in big data in healthcare

ALSO INCLUDED

Exclusive Webinars with Industry Experts

For SCMP Research China Digital Health Report 2021 purchasers, please check your email for personalized registration or reach out to research@scmp.com for more information.

Session 1:
How are AI and IoT improving the consumer healthcare experience?

Aug 26, 2021 | 11:00AM - 12:30PM

PLAYBACK

Session 2:
Is biotech set to change the landscape of Hong Kong healthcare?

Sep 16, 2021 | 11:00AM - 12:30PM

Session 3:
Investment opportunities in healthcare for 2021 and beyond

Oct 28, 2021 | 11:00AM - 12:30PM

COMING SOON

Dr. Ngai-tseung Cheung

Head of Information Technology & Health Informatics

Session 1: Hosted on Aug 26, 2021

Megan Lam

Co-founder & CEO Neurum Health

Session 1: Hosted on Aug 26, 2021

Dr. Kee Yuan Ngiam

Group CTO National University Health System Megan Lam Co-founder & CEO

Session 1: Hosted on Aug 26, 2021

Dr. Matthew Man

Founder & CEO
Megasoft Limited

Session 1: Hosted on Aug 26, 2021

Dr. Shawn Leung

Founder, Chairman & CEO SinoMab BioScience

Session 2: Sep 16, 2021 | 11:00AM - 12:30PM

Mr. Stanley Sy

Chief Executive Officer Sanomics

Session 2: Sep 16, 2021 | 11:00AM - 12:30PM

Danny Yeung

Co-founder & CEO Prenetics Group

Session 2: Sep 16, 2021 | 11:00AM - 12:30PM

The transformative use of digital and data tools in global health and development cannot be understated. And the contributions from China to the global efforts are promising and impactful. It is terrific to see such a comprehensive and well-organized report on this critical and evolving area.

Steve Davis

Co-chair, WHO Digital Health Technical Advisory Group
Senior Strategy Advisor and Interim China Country Director, Bill & Melinda Gates Foundation

China Digital Health Report 2021 conducts a systematic study on the segments and representative enterprises in China's digital health field, and comprehensively analyzes the status and impact of China's digital health industry. This is helpful for enterprises and investment institutions to understand the latest industry dynamics, grasp the trends, and jointly promote the growth.

Mr. Yusheng Han

Founder & CEO of Burning Rock

This is a good reference to outline the concepts of digital health and discuss the potential market in China. Insights from this report encourage the future development of digital health among healthcare professionals, policymakers, and potential investors.

Professor Kelvin Tsoi

President of the International Society for Digital Health
Founder and Director, of DeepHealth

PRICING PLANS

Choose the plan that suits you best

Individual Plan

Individual access to China Digital Health Report 2021
Individual access to live webinar sessions and playback with digital health experts

US$400

Group Plan

Team access to China Digital Health Report 2021
Team access to live webinar sessions and playback with digital health experts

Related Reports

Sign up for our communications to get 10% welcome discount, a free preview of the China Digital Health Report 2021, and other latest updates

By submitting your email address, you consent to our T&C and Privacy Policy. You may opt out at any time.

For business enquiries, customer feedback and questions, email us at research@scmp.com

ABOUT US
PRIVACY POLICY
TERMS & CONDITIONS

The content of this report is for information purposes only. Whilst every effort has been made to ensure accuracy, no warranty, expressed or implied is given on merchantability, accuracy, reliability and correctness of the content. We expressly exclude any and all liability, to the extent permissible under law, including but not limited to tort, negligence, all losses, damages, costs suffered or incurred by anyone in reliance on the report. You are specifically drawn to the attention that the report is not meant to be relied on and should not be construed as advice of any kind or the basis for making any commercial decision including but not limited to any investment decisions. The report may consist of opinion, data and information obtained from a wide range of sources, both public and private, market research, interviews and third party resources. We cite specific sources where data, research or insights are obtained from any third party. Any trademarks or service marks used in this report are the marks of their respective owners and may not have contributed to the content of the report and should not be read or construed as having made any endorsement to the content of the same. All rights in such marks are reserved by their respective owners. Purchase is nonrefundable and is subject to terms and conditions. Please visit here for details.